| The impact of stress on body function: A review H Yaribeygi, Y Panahi, H Sahraei, TP Johnston, A Sahebkar EXCLI journal 16, 1057, 2017 | 1555 | 2017 |
| The use of mucoadhesive polymers in buccal drug delivery N Salamat-Miller, M Chittchang, TP Johnston Advanced drug delivery reviews 57 (11), 1666-1691, 2005 | 997 | 2005 |
| Therapeutic effects of curcumin in inflammatory and immune‐mediated diseases: A nature‐made jack‐of‐all‐trades? E Abdollahi, AA Momtazi, TP Johnston, A Sahebkar Journal of cellular physiology 233 (2), 830-848, 2018 | 279 | 2018 |
| COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up A Tajbakhsh, SM Gheibi Hayat, H Taghizadeh, A Akbari, M Inabadi, ... Expert review of anti-infective therapy 19 (3), 345-357, 2021 | 278 | 2021 |
| Curcumin use in pulmonary diseases: State of the art and future perspectives D Lelli, A Sahebkar, TP Johnston, C Pedone Pharmacological research 115, 133-148, 2017 | 266 | 2017 |
| Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms Y Panahi, Y Ahmadi, M Teymouri, TP Johnston, A Sahebkar Journal of cellular physiology 233 (1), 141-152, 2018 | 261 | 2018 |
| Curcumin as a MicroRNA regulator in cancer: a review AA Momtazi, F Shahabipour, S Khatibi, TP Johnston, M Pirro, A Sahebkar Reviews of Physiology, Biochemistry and Pharmacology, Vol. 171, 1-38, 2016 | 241 | 2016 |
| Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and toll-like receptor pathways K Koushki, SK Shahbaz, K Mashayekhi, M Sadeghi, ZD Zayeri, MY Taba, ... Clinical reviews in allergy & immunology 60, 175-199, 2021 | 235 | 2021 |
| Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial Y Panahi, N Khalili, E Sahebi, S Namazi, LE Simental-Mendía, M Majeed, ... Drug research 68 (07), 403-409, 2018 | 226 | 2018 |
| Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice TP Johnston, MA Punjabi, CJ Froelich Pharmaceutical research 9, 425-434, 1992 | 222 | 1992 |
| Mechanism of poloxamer 407-induced hypertriglyceridemia in the rat TP Johnston, WK Palmer Biochemical pharmacology 46 (6), 1037-1042, 1993 | 216 | 1993 |
| Curcumin: A natural modulator of immune cells in systemic lupus erythematosus AA Momtazi-Borojeni, SM Haftcheshmeh, SA Esmaeili, TP Johnston, ... Autoimmunity reviews 17 (2), 125-135, 2018 | 208 | 2018 |
| Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features M Teymouri, M Pirro, TP Johnston, A Sahebkar BioFactors 43 (3), 331-346, 2017 | 192 | 2017 |
| Poloxamer 407—mediated changes in plasma cholesterol and triglycerides following intraperitoneal injection to rats ZGM Wout, EA Pec, JA Maggiore, RH Williams, P Palicharla, TP Johnston PDA Journal of Pharmaceutical Science and Technology 46 (6), 192-200, 1992 | 189 | 1992 |
| Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium N Salamat-Miller, TP Johnston International journal of Pharmaceutics 294 (1-2), 201-216, 2005 | 183 | 2005 |
| Curcumin, hemostasis, thrombosis, and coagulation F Keihanian, A Saeidinia, RK Bagheri, TP Johnston, A Sahebkar Journal of cellular physiology 233 (6), 4497-4511, 2018 | 176 | 2018 |
| Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the rat EA Pec, ZG Wout, TP Johnston Journal of pharmaceutical sciences 81 (7), 626-630, 1992 | 170 | 1992 |
| Evidence of curcumin and curcumin analogue effects in skin diseases: A narrative review Y Panahi, O Fazlolahzadeh, SL Atkin, M Majeed, AE Butler, TP Johnston, ... Journal of cellular physiology 234 (2), 1165-1178, 2019 | 165 | 2019 |
| The P-407–induced murine model of dose-controlled hyperlipidemia and atherosclerosis: a review of findings to date TP Johnston Journal of cardiovascular pharmacology 43 (4), 595-606, 2004 | 148 | 2004 |
| Toxicological evaluation of poloxamer vehicles for intramuscular use TP Johnston, SC Miller PDA Journal of Pharmaceutical Science and Technology 39 (2), 83-89, 1985 | 144 | 1985 |
